These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 11326651

  • 21. [Prostate cancer after prostatectomy for benign prostatic hyperplasia].
    Hua L, Zhang J, Wu H, Sui Y, Zhang W, Qian L, Wang Z.
    Zhonghua Nan Ke Xue; 2004 Aug; 10(8):612-3. PubMed ID: 15362527
    [Abstract] [Full Text] [Related]

  • 22. The periurethral glands do not significantly influence the serum prostate specific antigen concentration.
    Oesterling JE, Tekchandani AH, Martin SK, Bergstralh EJ, Reichstein E, Diamandis EP, Yemoto C, Stamey TA.
    J Urol; 1996 May; 155(5):1658-60. PubMed ID: 8627847
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Role of transition zone sampling by TURP in patients with raised PSA and multiple negative transrectal ultrasound-guided prostatic biopsies.
    Radhakrishnan S, Dorkin TJ, Sheikh N, Greene DR.
    Prostate Cancer Prostatic Dis; 2004 May; 7(4):338-42. PubMed ID: 15365579
    [Abstract] [Full Text] [Related]

  • 25. Effect of 13-cis-retinoic acid on serum prostate-specific antigen levels in patients with recurrent prostate cancer after radical prostatectomy.
    Shalev M, Thompson TC, Frolov A, Lippman SM, Hong WK, Fritsche H, Kadmon D.
    Clin Cancer Res; 2000 Oct; 6(10):3845-9. PubMed ID: 11051228
    [Abstract] [Full Text] [Related]

  • 26. Tumor cytoreduction results in better response to androgen ablation--a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer.
    Qin XJ, Ma CG, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, Shen YJ, Zhu Y, Zhu YP, Shi GH, Xiao WJ, Lin GW, Swanson GP.
    Urol Oncol; 2012 Oct; 30(2):145-9. PubMed ID: 20451424
    [Abstract] [Full Text] [Related]

  • 27. Role of free to total prostate specific antigen ratio in serum in the diagnosis of prostatic enlargement.
    Bhuiyan AK, Kibria SA, Subhan SS.
    Bangladesh Med Res Counc Bull; 2004 Aug; 30(2):51-9. PubMed ID: 15813483
    [Abstract] [Full Text] [Related]

  • 28. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
    Stamey TA, Johnstone IM, McNeal JE, Lu AY, Yemoto CM.
    J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Prostate specific antigen nadir determined using ultra-sensitive prostate specific antigen as a predictor of biochemical progression after radical prostatectomy in Japanese males.
    Kinoshita H, Kamoto T, Nishiyama H, Nakamura E, Matsuda T, Ogawa O.
    Int J Urol; 2007 Oct; 14(10):930-4; discussion 934. PubMed ID: 17880291
    [Abstract] [Full Text] [Related]

  • 31. Does benign prostatic tissue contribute to measurable PSA levels after radical prostatectomy?
    Godoy G, Tareen BU, Lepor H.
    Urology; 2009 Jul; 74(1):167-70. PubMed ID: 19406457
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [A case of ductal carcinoma of the prostate after transurethral resection of prostate].
    Izumi K, Kanno H, Umemoto S, Hasumi H, Osada Y, Ota J, Tsuchiya F, Ogino I, Harada M.
    Hinyokika Kiyo; 2007 May; 53(5):315-8. PubMed ID: 17561717
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Prostatic cancer developing after transurethral resection of the prostate for benign prostatic hyperplasia].
    Tanaka Y, Aoyama H, Momose H, Ono T, Samma S, Tanaka N, Akiyama T, Tani Y, Masuda Y, Matsuki H, Tani M, Tanaka M.
    Hinyokika Kiyo; 2001 Jan; 47(1):11-4. PubMed ID: 11235214
    [Abstract] [Full Text] [Related]

  • 36. Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence.
    Delongchamps NB, Zerbib M, Mejean A, Rouach Y, Debre B, Peyromaure M.
    Can J Urol; 2009 Oct; 16(5):4813-9. PubMed ID: 19796456
    [Abstract] [Full Text] [Related]

  • 37. [Transurethral resection of prostate just following high intensity focused ultrasound in localized prostate cancer--trial for early removal of the urethral catheter].
    Otsuki H, Sumitomo M, Umeda S, Shirotake S, Tobe M, Ito K, Asano T, Nagakura K, Hayakawa M.
    Hinyokika Kiyo; 2008 Mar; 54(3):189-95. PubMed ID: 18411774
    [Abstract] [Full Text] [Related]

  • 38. Prostate-specific antigen level at initiation of hormonal therapy after prostate-specific antigen failure following prostatectomy or radiotherapy and therapeutic response.
    Alexander BM, Chen MH, Carroll P, D'Amico AV.
    Urology; 2007 Aug; 70(2):320-3. PubMed ID: 17826497
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer.
    Efstathiou JA, Skowronski RY, Coen JJ, Grocela JA, Hirsch AE, Zietman AL.
    Int J Radiat Oncol Biol Phys; 2008 Aug 01; 71(5):1302-8. PubMed ID: 18262732
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.